- Previous Close
3.2000 - Open
3.3500 - Bid --
- Ask --
- Day's Range
3.0800 - 3.3700 - 52 Week Range
2.1500 - 98.7500 - Volume
289,331 - Avg. Volume
2,920,591 - Market Cap (intraday)
19.083M - Beta (5Y Monthly) -0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-11.6400 - Earnings Date Jan 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.62
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
www.allurion.comRecent News: ALUR
View MorePerformance Overview: ALUR
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALUR
View MoreValuation Measures
Market Cap
19.08M
Enterprise Value
41.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.22
Price/Book (mrq)
--
Enterprise Value/Revenue
1.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-81.43%
Return on Assets (ttm)
-60.03%
Return on Equity (ttm)
--
Revenue (ttm)
32.11M
Net Income Avi to Common (ttm)
-26.15M
Diluted EPS (ttm)
-11.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
15.38M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--